Vivorté, Inc.

Vivorté is a R&D and manufacturing company focused on developing and commercializing novel bone substitute cements targeting emerging orthopedic treatments.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Louisville, KY, USA
  • Currency USD
  • Founded December 2010
  • Employees 5
  • Incorporation Type C-corp
  • Website

Company Summary

Vivorté is a commercial-stage orthobiologic company, with two novel FDA-approved bone substitute cements, plus a pipeline of new technologies targeting emerging orthopedic treatments. The company boasts a fully integrated operating facility, complete with controlled environment processing rooms housing state-of-the-art manufacturing equipment. Both the facility and quality system are FDA inspected and ISO 13485:2016 certified.


  • Co-Founder

    Ruth worked for more than 18 years at Johnson & Johnson. Ms. Voor was the Executive Director of Drug Eluting Stent Commercialization for J&J, leading the team that took CYPHER® Drug Eluting Stent from concept to launch and global approval in less than 4 years, achieving $1B in US sales in the first 9 months. She received a BS from the United States Naval Academy.

  • CSO and Co-Founder

    Dr. Voor is the Director of the Orthopaedic Bioengineering Laboratory at the University of Louisville. He has over 60 peer-reviewed publications, has secured over $3M in research funding and consulted on projects with many large orthopedic companies. Dr. Voor has authored several patents and has a bone fixation device, which is sold by DePuy Spine, Inc. He received his PhD from Tulane University’s Department of Biomedical Engineering.

  • Mark has extensive experience leading commercial organizations within the medical device industry. Previously, he was Senior Director of Sales and Marketing at DCI Donor Services, leading the commercialization within the orthopedics, spine and wound care market segments. Mr. Wagner also held leadership positions at AmerisourceBergen, Angiotech Pharmaceuticals and RTI Surgical. He received his MBA from Northwestern (Kellogg).

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free